Angiotensin 1/2 (5-7): Vasoconstrictor Peptide for Renin-Angiotensin System Research

Executive Summary: Angiotensin 1/2 (5-7) (H2N-Ile-His-Pro-OH) is a tripeptide hormone derived from angiotensinogen, exerting significant vasoconstrictive effects and raising blood pressure via the renin-angiotensin system (RAS) (Oliveira et al., 2025). The peptide displays high solubility in DMSO, ethanol, and water, achieving ≥36.5 mg/mL in DMSO (APExBIO product dossier). Its activity profile extends to potentiating SARS-CoV-2 spike protein binding to host receptors, highlighting relevance for virology research (Oliveira et al., 2025). Purity is confirmed by HPLC (98.36%) and identity by mass spectrometry. Proper handling and storage ensure optimal stability and reproducibility.

Biological Rationale

Angiotensin peptides are essential regulators within the renin-angiotensin system (RAS), controlling cardiovascular and renal function [Oliveira et al., 2025]. Angiotensin 1/2 (5-7) is enzymatically generated from angiotensin I and II by N-terminal truncation, resulting in a tripeptide with the sequence H2N-Ile-His-Pro-OH. The precursor, angiotensinogen, is synthesized in the liver and cleaved by renin in the kidney to form angiotensin I. Further cleavage by ACE or other proteases yields active peptides, including angiotensin 1/2 (5-7). This peptide acts as a potent vasoconstrictor, modulating systemic blood pressure and fluid balance. In addition to its classical cardiovascular role, recent findings highlight its capacity to enhance SARS-CoV-2 spike protein binding to the AXL receptor, suggesting a mechanistic link between RAS peptides and viral pathogenesis [Oliveira et al., 2025].

Mechanism of Action of Angiotensin 1/2 (5-7)

Angiotensin 1/2 (5-7) exerts its effects primarily through vasoconstriction. It interacts with cell-surface receptors, promoting smooth muscle contraction and elevating blood pressure [Angiotensin 1/2 (5-7): A Precision Vasoconstrictor Peptide]. The peptide's dipsogenic activity stimulates thirst and water intake. Unlike its longer precursors, it is a truncated form lacking the N-terminal residues, which enhances its ability to modulate spike–AXL binding in the context of SARS-CoV-2 infection [Oliveira et al., 2025]. The molecular formula C17H27N5O4 and molecular weight 365.43 Da facilitate precise dosing in experimental workflows. Its activity is tightly linked to specific amino acid sequence and structure, as confirmed by mass spectrometry and HPLC analyses.

Evidence & Benchmarks

• Angiotensin 1/2 (5-7) demonstrates a 2.7-fold increase in SARS-CoV-2 spike–AXL binding in antibody-based assays (Oliveira et al., 2025).
• The peptide achieves solubility of ≥36.5 mg/mL in DMSO, and ≥50 mg/mL in both ethanol and water at room temperature (APExBIO).
• Purity of commercial Angiotensin 1/2 (5-7) lots is verified at ≥98.36% by HPLC, with identity confirmed by mass spectrometry (APExBIO).
• Classical vasoconstrictor activity is confirmed in mammalian vascular smooth muscle tissue assays [Mechanistic Powerhouse for Translational Studies].
• Storage at -20°C preserves peptide integrity; solutions are stable for short-term use but not recommended for long-term storage to avoid hydrolysis or oxidation (APExBIO).

This article extends prior discussions such as "A Precision Vasoconstrictor Peptide Hormone" by integrating new findings on SARS-CoV-2 spike binding; it also deepens mechanistic exploration compared to "Mechanistic Powerhouse for Translational Studies" and updates solubility and workflow parameters from "Precision Peptide for RAS & Viral Pathogenesis".

Applications, Limits & Misconceptions

Angiotensin 1/2 (5-7) is routinely used in:

• RAS pathway dissection and hypertension modeling.
• Blood pressure regulation studies in vivo and ex vivo.
• SARS-CoV-2 viral pathogenesis research, especially regarding spike protein–host receptor interactions (Oliveira et al., 2025).
• Pharmacological screening for receptor affinity and antagonist development.

However, its effects are context-dependent and should not be extrapolated to all RAS functions. The peptide is not a direct therapeutic agent; rather, it is a research tool for mechanistic and translational studies [Unlocking New Horizons in Cardiovascular Research].

Common Pitfalls or Misconceptions

• This peptide does not substitute for full-length angiotensin II (1–8) in all bioassays.
• It should not be used as a direct therapeutic for hypertension—its clinical efficacy is unproven.
• Long-term storage of dissolved peptide leads to degradation; always prepare fresh aliquots.
• Effects on non-vascular tissues are poorly characterized and should not be assumed.
• It is not interchangeable with other RAS peptides in receptor specificity assays.

Workflow Integration & Parameters

Angiotensin 1/2 (5-7) (SKU: A1049, APExBIO) is supplied as a solid, stable at -20°C. It dissolves efficiently in DMSO, ethanol, or water, reaching ≥36.5 mg/mL (DMSO) and ≥50 mg/mL (ethanol, water) at room temperature. Avoid repeated freeze-thaw cycles. For solution preparation, use sterile, nuclease-free solvents and filter if needed. The peptide is compatible with in vitro, ex vivo, and small-animal in vivo experimental models. Shipping is on blue ice to preserve stability. For quality control, each lot is validated by HPLC (≥98.36% purity) and mass spectrometry. For comparative workflows, see the updated parameters in "Precision Peptide for RAS & Viral Pathogenesis", which this article updates with new handling and solubility benchmarks.

Conclusion & Outlook

Angiotensin 1/2 (5-7) is a rigorously characterized, high-purity vasoconstrictor peptide for RAS and virology research. Its reproducible solubility and validated activity make it a preferred choice for blood pressure regulation, hypertension modeling, and emerging viral pathogenesis studies. As new data on peptide–virus interactions emerge, this tool will remain indispensable for mechanistic and translational research. For detailed product specifications and ordering information, refer to the APExBIO product page.